https://www.selleckchem.com/products/gsk503.html
This feedback loop between EMT and immunosuppression promotes tumor progression. For therapy directly targeting EMT has been challenging, the elucidation of the interactive regulation of EMT and immunosuppression is desirable for developing new therapeutic approaches in cancer. The combination of immune checkpoint inhibitors (ICIs) and immunotherapy targeting immunosuppressive cells could be a promising therapy for EMT.A 23-year-old primigravida at 20 weeks of gestation presented to our hospital with undifferentiated febrile illness and
Like
Comment
Share
